Characteristics of the study population
Characteristic . | Total cohort . | Antithrombin cohort . | Protein C cohort . | Protein S cohort . | ||||
---|---|---|---|---|---|---|---|---|
Deficient . | Nondeficient . | Deficient . | Nondeficient . | Deficient . | Nondeficient . | Deficient . | Nondeficient . | |
Subject, n | 70 | 64 | 22 | 16* | 29 | 22† | 19‡ | 26§ |
Male sex, n (%) | 35 (50) | 34 (51) | 12 (54) | 7 (43.7) | 16 (55) | 13 (59) | 6 (32) | 14 (50) |
Median age at enrollment (range), y | 12 (1-17) | 13 (5-17) | 12 (5-16) | 13 (8-17) | 12 (2-17) | 14 (5-16) | 12 (6-17) | 14 (5-17) |
Observation years | 287 | 248 | ||||||
Mean length of follow-up (range), y | 4 (1-16) | 3.9 (1-13) |
Characteristic . | Total cohort . | Antithrombin cohort . | Protein C cohort . | Protein S cohort . | ||||
---|---|---|---|---|---|---|---|---|
Deficient . | Nondeficient . | Deficient . | Nondeficient . | Deficient . | Nondeficient . | Deficient . | Nondeficient . | |
Subject, n | 70 | 64 | 22 | 16* | 29 | 22† | 19‡ | 26§ |
Male sex, n (%) | 35 (50) | 34 (51) | 12 (54) | 7 (43.7) | 16 (55) | 13 (59) | 6 (32) | 14 (50) |
Median age at enrollment (range), y | 12 (1-17) | 13 (5-17) | 12 (5-16) | 13 (8-17) | 12 (2-17) | 14 (5-16) | 12 (6-17) | 14 (5-17) |
Observation years | 287 | 248 | ||||||
Mean length of follow-up (range), y | 4 (1-16) | 3.9 (1-13) |